Informa plc (LON:INF) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Informa plc (LON:INF) has been assigned an average recommendation of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is GBX 1,105.

Several brokerages recently issued reports on INF. Panmure Gordon reaffirmed a “buy” rating and set a GBX 1,200 price objective on shares of Informa in a research report on Wednesday, November 19th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Informa from GBX 1,000 to GBX 1,140 and gave the company a “buy” rating in a report on Wednesday, October 29th. JPMorgan Chase & Co. decreased their price objective on shares of Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating for the company in a report on Monday. Citigroup started coverage on shares of Informa in a research report on Monday. They set a “neutral” rating and a GBX 975 target price on the stock. Finally, UBS Group reaffirmed a “buy” rating and issued a GBX 1,055 price target on shares of Informa in a research report on Friday, November 7th.

Informa Trading Down 1.6%

LON:INF traded down GBX 14.20 on Monday, reaching GBX 886.80. The stock had a trading volume of 2,321,778 shares, compared to its average volume of 3,303,222. The company has a market cap of £11.34 billion, a price-to-earnings ratio of 161.24, a P/E/G ratio of 0.75 and a beta of 1.12. Informa has a 12-month low of GBX 634.20 and a 12-month high of GBX 1,000. The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70. The firm’s fifty day moving average is GBX 918.36 and its two-hundred day moving average is GBX 897.21.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.